BMY

百时美施贵宝
NYSE

实时行情|Nasdaq Last Sale

54.73
+0.36
+0.66%
交易中 14:59 04/02 EDT
开盘
54.87
昨收
54.37
最高
55.31
最低
53.58
成交量
833.36万
成交额
--
52周最高
68.34
52周最低
42.48
市值
1,238.25亿
市盈率(TTM)
24.91
分时
5日
1月
3月
1年
5年

分析师评级

16位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测BMY价格均价为70.82,最高价位79.00,最低价为50.00。

EPS

BMY 新闻

更多
  • Top Ranked Income Stocks to Buy for April 2nd
  • Zacks · 2小时前
  • Wall Street analysts bet on a bottom and upgrade more stocks, including Disney and Beyond Meat
  • CNBC.com · 4小时前
  • With $1.1B in hand, life sciences investor Flagship rewrites its rulebook
  • American City Business Journals · 7小时前
  • Morgan Stanley likes Bristol-Myers Squibb in premarket analyst action
  • Seeking Alpha - Article · 7小时前

所属板块

制药
+1.35%
制药与医学研究
+1.38%

热门股票

代码
价格
涨跌幅

BMY 简况

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world. The Company’s subsidiary is Celgene Corp.
展开

微牛提供Bristol-Myers Squibb Co(NYSE-BMY)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的BMY股票新闻,以帮助您做出投资决策。